Cell, 2012 · DOI: 10.1016/j.cell.2012.08.020 · Published: September 14, 2012
The study investigates the ability of neural stem cells (NSCs) to promote axonal regeneration after severe spinal cord injury in rats. NSCs were grafted into the injury site within a fibrin matrix containing growth factors to enhance survival and integration. The grafted NSCs differentiated into various cell types, including neurons that extended axons over remarkably long distances within the host spinal cord. These newly grown axons formed connections (synapses) with the host's existing neurons. The research also found that this axonal growth and functional recovery were partially dependent on a cellular signaling pathway called mTOR. Additionally, human neural stem cells showed similar growth capabilities, suggesting potential translational relevance for treating spinal cord injuries in humans.
The study suggests that neural stem cell transplantation, combined with supportive matrices and growth factors, holds promise as a therapeutic strategy for severe spinal cord injuries.
The successful use of human neural stem cells, already in clinical trials for ALS, further supports the translational potential of this approach.
The findings indicate that properties intrinsic to early-stage neurons can overcome the inhibitory environment of the adult CNS, paving the way for novel strategies to promote axonal regeneration.